LONGEVITY GLOBAL

THE
LONGEVITY SUMMIT 2023

THE FUTURE OF MEDICINE:
ELIMINATING DISEASE OF AGING

December 5-6 | Buck Institute for Research on Aging
Novato, CA

LEARN FROM YOUR PEERS

Welcome to The Longevity Summit’s third annual event! We gather the entire longevity ecosystem to tackle the aging problem: longevity entrepreneurs, existing pharma and biotech companies, investors, researchers, and government organizations. Developing aging interventions may represent the largest value creation journey in human history, and it’s going to require a coordinated industry.

The Longevity Summit creates a peer to peer learning environment focused on the business of longevity and the key areas of innovation needed to progress the longevity industry.

HYBRID

LONGEVITY
FOCUSED

NETWORKING
ENABLED

BECOME A SPONSOR

This event is meant for those in a position to significantly impact the longevity industry, whether as an entrepreneur, life sciences executive, investor, researcher, influencer, or government representative and do not have a sales interest in our audience.

Interested in showcasing your products/services? Apply to sponsor.

OUR SPEAKERS

See below for our confirmed speakers for 2023. The Longevity Summit will feature 25+ speakers over two days.

Apply to Speak

George Church, PhD
Professor
Harvard University

Nikolina Lauc
CEO
GlycanAge

Bryan Johnson
Founder & CEO
Blueprint

Pankaj Kapahi, PhD
Professor
Buck Institute

Janice Chen, PhD
CTO & Co-founder
Mammoth Biosciences

Kristen Fortney, PhD
CEO & Co-founder
BioAge Labs

Eric Verdin, MD
CEO/President
Buck Institute

Omri Amirov-Drory, PhD
CEO & Co-founder
Renewal Bio

Robin Mansukhani
CEO
Deciduous Therapeutics

Steve Horvath, PhD
Principal Investigator
Altos Labs

Daisy Robinton, PhD
CEO & Co-founder
Oviva Therapeutics

Alessandra Zonari, PhD
CSO
One Skin

Peter Fedichev, PhD
CEO & Co-founder
Gero

THEMES COVERED

Developing aging therapies requires both new science and new business models. The Longevity Summit will explore the key topics that leaders within the industry need to know in order to turn longevity research into prescribable medicine. Join us as we explore the following topics…